Evidence map›Paper›PMID 32677762›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2020

Trans fatty acid elimination policy in member states of the Eurasian Economic Union: Implementation challenges and capacity for enforcement.

Andrey Demin, Bianca Løge, Olga Zhiteneva, Chizuru Nishida, Stephen Whiting, Holly Rippin, Christian Delles, Saliya Karymbaeva, Kremlin Wickramasinghe, João Breda

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 5 countries.

Andrey DeminInstitute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.ORCID 0000-0002-5650-5636
Bianca LøgeWorld Health Organization, Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.ORCID 0000-0002-4858-2068
Olga ZhitenevaWorld Health Organization, Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.
Chizuru NishidaDepartment of Nutrition and Food Safety, World Health Organization, Geneva, Switzerland.ORCID 0000-0002-4608-7143
Stephen WhitingWorld Health Organization, Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.ORCID 0000-0002-3652-0708
Holly RippinWorld Health Organization, Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.ORCID 0000-0002-8879-3978
Christian DellesLancet Commission on Hypertension Group.ORCID 0000-0003-2238-2612
Saliya KarymbaevaDepartment for Sanitary, Phytosanitary and Veterinary Measures, Eurasian Economic Commission, Moscow, Russian Federation.
Kremlin WickramasingheWorld Health Organization, Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.ORCID 0000-0001-9497-7901
João BredaWorld Health Organization, WHO Regional Office for Europe, Office for Prevention and Control of Noncommunicable Diseases, Copenhagen, Denmark.ORCID 0000-0002-8177-4926
WHO European Office for the Prevention and Control of NCD · RULancet Laboratories · ZANew Economic School · RUSechenov University · RUWorld Health Organization · CHWorld Health Organization Regional Office for Europe · DK

Funding

CDC HHSWorld Health Organization 001
6 · The paper itself

Abstract

Removing trans fatty acids (TFAs) from the food supply in the Eurasian Economic Union (EAEU) are one of the most effective public health interventions for reducing the risk of noncommunicable diseases. EAEU Member States have taken important steps to reduce TFA in oil and fat products to <2% of the total fat content. The authors summarize existing policies in the region, identify challenges in implementation, and suggest measures to strengthen regulation to achieve compliance with WHO guidelines. Documents published between 2011 and 2019 in Russian and English were reviewed, including EAEU and Member State restrictions on TFA in food products, data on TFA content in foods, and food labeling policies. The EAEU has established TFA limits in oil and fat products; however, Member States are currently not achieving the WHO guideline of <2% of total fat content in food products. A lack of harmonized monitoring systems and sanctions create challenges in monitoring compliance. The authors recommend developing an EAEU-wide monitoring system to test TFA content and organize population intake surveys. Discrepancies exist within regulatory frameworks that allow higher levels of TFAs in dairy products and infant formula. The authors recommend extending the current regulation to mandate TFA limits for all food products. Research found that strengthening regulation to meet the WHO guidelines should be prioritized. Member States should implement actions to replace TFAs with healthier fats, develop standardized surveillance methods, and scale-up strategic communication to ensure the food industry and the public follow public health recommendations to protect the health of the EAEU population.

Indexed as

HypertensionFood LabelingHumansNutrition PolicyTrans Fatty AcidsTrans Fatty Acidscoronary heart diseaseEurasian economic union (EAEU)Technical RegulationTrans fatty acid (TFA)World Health Organization (WHO)

Identifiers

PMID32677762
PMCPMC8029925
OpenAlexW3043488449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.